35
Participants
Start Date
May 14, 2020
Primary Completion Date
February 28, 2022
Study Completion Date
March 30, 2022
Interleukin-7
Intramuscular (IM) administration of CYT107 at 3 μg/kg followed, after 48hrs of observation, by 10 μg/kg twice a week for 2 weeks or
Placebos
Intramuscular (IM) placebo (normal saline) at the same frequency
Sandwell Birmingham Hospital, Birmingham
Sandwell Birmingham Hospital, Birmingham
Royal Preston Hospital, Preston
Sunderland Royal Hospital, Sunderland
Bradford Institute for Health Research, Bradford
ST JAMES's UNIVERSITY HOSPITAL, Leeds
Medway Maritime Hospital, London
Guy's and St Thomas' NHS Foundation Trust, London
King'S College Hospital, London
Wythenshawe Hospital/ Manchester Royal Infirmary, Manchester
North Manchester General Hospital, Manchester
Royal Victoria Infirmary and Freeman Hospital, Newcastle
Watford General Hospital, Watford
Collaborators (1)
Amarex Clinical Research
OTHER
Revimmune
INDUSTRY